Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer patients

NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced Results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer (CRC) patients during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American … [Read more…]

NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy and Biologics for Advanced CRC Patients More Common Than Switching to Drug Regimens with Alternative Mechanism of Action

NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium SAN FRANCISCO–(BUSINESS WIRE)–NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced new real-world data on treatment patterns for patients with advanced colorectal cancer (CRC) during a poster session at the 2020 Gastrointestinal Cancer Symposium sponsored by the American Society of Clinical … [Read more…]

Horizon Therapeutics plc Announces Changes in Research and Development Organization

– Scott Brun, M.D. Named Senior R&D Advisor – DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and external search; Srini Ramanathan, Ph.D., group vice president, development sciences and San Francisco site head and Melanie Gloria, … [Read more…]

DeciBio Spins off Technology Products as a Subsidiary Entity, DeciBio Analytics

LOS ANGELES–(BUSINESS WIRE)–#bigdata–Last year, DeciBio Consulting announced the formation of DeciBio Analytics, a subsidiary entity that develops market intelligence informatics tools and technologies and informatics-oriented consulting work. With the mission to accelerate commercialization of innovation in the precision medicine space by building novel and propriety solutions that empower our clients, DeciBio Analytics will continue to … [Read more…]

Gloo personal growth platform powers new research partnership with Behavioral Health Learning Network

BOULDER, Colo.–(BUSINESS WIRE)–Gloo, LLC, a trusted technology platform provider for organizations that champion personal growth, announced today that it is partnering with the Psychiatry and Behavioral Health Learning Network (PBHLN) to power a virtual center of excellence aimed at improving patient outcomes among the nation’s mental health treatment and addiction recovery providers. HMP Global, a … [Read more…]

China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production

TAIZHOU, China–(BUSINESS WIRE)–China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), announced today that it will be increasing its production of its entire TCM product line, in response to recent Chinese government pronouncements signaling … [Read more…]

The Behavioral Health Provider Network Kicks Off 2-Day Continuing Education Conference Today

The Enhancing Your Impact conference brought to BHPN providers at no cost focuses on advancing the practice of behavioral health and evidence-based treatment throughout Northern California WALNUT CREEK, Calif.–(BUSINESS WIRE)–The Behavioral Health Provider Network (BHPN), a non-profit organization headquartered in Walnut Creek, is hosting its first annual conference for continuing education, Enhancing Your Impact, in … [Read more…]

TAZVERIK™ (Tazemetostat) Approved for the Treatment of Epithelioid Sarcoma, Available from Onco360®

LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Epizyme to be the exclusive specialty pharmacy partner for TAZVERIK™ (Tazemetostat), a new oral treatment for adult and pediatric patients (aged 16 years and older) with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. “The approval of TAZVERIK as … [Read more…]

Japan Hospital Hematology and Flow Cytometry Markets, 2020 – Agilent Technologies, CellaVision, Roche & Sysmex – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2020 Japan Hospital Hematology and Flow Cytometry Markets: Supplier Shares, Sales Segment Forecasts and Strategic Profiles of Leading Competitors” report has been added to ResearchAndMarkets.com’s offering. This new report from the author contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including: Major … [Read more…]

2020 Biologic Drug Product Contract Manufacturer Quality Benchmarking Report – Optimize Operational and Marketing Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biologic Drug Product Contract Manufacturer Quality Benchmarking (3rd Edition)” report has been added to ResearchAndMarkets.com’s offering. This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 23 performance attributes specific to outsourced … [Read more…]